Novanta (NOVT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
The annual meeting will be held virtually on May 28, 2026, with shareholders able to vote and ask questions online.
Key proposals include electing nine directors, an advisory vote on executive compensation, and appointing Deloitte & Touche LLP as auditor.
The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors, approval of executive compensation (say-on-pay), and the appointment of Deloitte & Touche LLP as auditor.
Cumulative voting is permitted for director elections, and a majority of votes cast is required for approval.
Shareholders may submit proposals for the 2027 meeting by December 30, 2026, and director nominations by January 24, 2027.
Board of directors and corporate governance
The Board consists of nine directors, eight of whom are independent; the Chair and CEO roles are combined.
Board committees include Audit, Compensation, ESG, and Transaction Committees, all chaired by independent directors.
The ESG Committee oversees board nominations, governance, sustainability, and cybersecurity.
Annual board and committee self-evaluations are conducted, and director tenure and age limits are in place.
Latest events from Novanta
- Revenue up 10.4% with record bookings, but operating income down 15.1% amid higher costs.NOVT
Q1 202611 May 2026 - Record revenue, strong bookings, and 2026 guidance project further growth and margin expansion.NOVT
Q4 202510 Apr 2026 - Q2 revenue up 2.8% to $236M, with medical growth offsetting weak industrial demand.NOVT
Q2 20242 Feb 2026 - Q3 2024 revenue up 10.3% to $244.4M, with acquisitions driving growth and flat organic sales.NOVT
Q3 202416 Jan 2026 - 2024 saw record cash flow, margin gains, and new products; 2025 targets 5% growth amid volatility.NOVT
Q4 202411 Dec 2025 - Annual meeting covers director elections, say-on-pay, auditor appointment, and ESG oversight.NOVT
Proxy Filing1 Dec 2025 - Q1 2025 delivered revenue growth, higher net income, and resilient guidance amid trade risks.NOVT
Q1 202528 Nov 2025 - Q2 2025 revenue up 2.2%, strong bookings, but operating income down 42% on higher costs.NOVT
Q2 202523 Nov 2025 - Q3 2025 saw higher revenue and adjusted EPS, but lower net income amid rising costs.NOVT
Q3 202513 Nov 2025